Pacient with chronic obstructive pulmonary disease adherence and satisfaction in community pharmacy
DOI:
https://doi.org/10.60103/phc.v24i5.781Keywords:
adherence to treatment; chronic obstructive pulmonary disease; asthma; inhalers; clinical pharmacy services.Abstract
Introduction: Numerous studies show that chronic obstructive pulmonary disease (COPD) is currently poorly controlled and under-diagnosed in many patients due to inadequate use of pharmacotherapy. Patients' knowledge of the complex medications they manage may not be sufficient. Here it is where the active dispensing by the community pharmacist plays an essential role. The objectives of this article are to measure adherence to treatment and satisfaction with the pharmacist's intervention in patients using inhalers.
Method: A cross-sectional and observational study was conducted in 105 patients. They were diagnosed with chronic obstructive pulmonary disease (COPD), were treated with inhalers and attended a community pharmacy. All patients made the Morisky-Green test of adherence to treatment and a test to assess the degree of satisfaction of patients using inhalers with the pharmacist's intervention.
Results: 60% of the patients showed adherence to treatment. Moreover, it is higher in women than in men and higher in patients aged 65 or more. Regarding the degree of satisfaction with the pharmacist, 52.4% of the patients considered the intervention carried out by the pharmacist was adequate and 43.8% totally adequate.
Conclusions: COPD patients have fairly improvable adherence to treatment and are satisfied with the pharmacist's intervention in improving the use of inhalers.
Downloads
References
Plaza V, Álvarez F, Calle M, Casanova C, Cosío BG, López-Viña A, et al. Consenso sobre el solapamiento de asma y EPOC (ACO) entre la Guía española de la EPOC (GesEPOC) y la Guía Española para el Manejo del Asma (GEMA). Arch Bronconeumol. 2017; 53:443–449.
Janjua S, Pike KC, Carr R, Coles A, Fortescue R, Batavia M. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2021; 9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2. PMID: 34496032; PMCID: PMC8425588.
Swieczkowski D, Poniatowski P, Merks P, Jaguszewski M. The pharmaceutical care in asthma - Polish and global perspective. Pneumonol Alergol Pol. 2016; 84(4):225-31. doi: 10.5603/PiAP.2016.0028. PMID: 27435349
Janjua S, Pike KC, Carr R, Coles A, Fortescue R, Batavia M. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2021; 9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2. PMID: 34496032; PMCID: PMC8425588
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. Respirology. 2017;22(3):575-601. doi: 10.1111/resp.13012.
Plaza V, Giner J, Rodrigo GJ, Dolovich MB, Sanchis J. Errors in the Use of Inhalers by Health Care Professionals: A Systematic Review. J Allergy Clin Immunol Pract. 2018; 6(3):987-995. doi: 10.1016/j.jaip.2017.12.032. Epub 2018 Jan 31. PMID: 29355645.
Imamura Y, Kawayama T, Kinoshita T, Sakazaki Y, Yoshida M, Takahashi K, Fujii K, Ando M, Hoshino T, Iwanaga T, Kohrogi H; Kyushu Asthma Seminar Investigators. Poor pharmacological adherence to inhaled medicines compared with oral medicines in Japanese patients with asthma and chronic obstructive pulmonary disease. Allergol Int. 2017; 66(3):482-484. doi: 10.1016/j.alit.2016.10.008. Epub 2016 Nov 22. PMID: 27887878.
Van Ganse E, Price D. Respiratory Medication Adherence: Toward a Common Language and a Shared Vision. J Allergy Clin Immunol Pract. 2016; 4(5):799-801. doi: 10.1016/j.jaip.2016.04.006. PMID: 27587313.
Ilardo ML, Speciale A. The Community Pharmacist: Perceived Barriers and Patient-Centered Care Communication. Int J Environ Res Public Health. 2020; 17(2):536. doi: 10.3390/ijerph17020536. PMID: 31952127; PMCID: PMC7013626.
Newbould V, Le Meur S, Goedecke T, Kurz X. Correction to: Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilance. Drug Saf. 2017; 40(12):1293. doi: 10.1007/s40264-017-0609-z. Erratum for: Drug Saf. 2017 Dec;40(12):1241-1248. PMID: 29116609; PMCID: PMC5688208.
de Bikuña Landa, B. G. Las especialidades farmacéuticas complejas: puede que para ti sea obvio, pero,¿es obvio para el paciente?. Semergen: revista española de medicina de familia. 2004; 30(10): 485-486.
Manzoor F, Wei L, Hussain A, Asif M, Shah SIA. Patient Satisfaction with Health Care Services; An Application of Physician's Behavior as a Moderator. Int J Environ Res Public Health. 2019;16(18):3318. doi: 10.3390/ijerph16183318. PMID: 31505840; PMCID: PMC6765938.
Flanagan P, Kainth S, Nissen L. Satisfaction survey for a medication management program: satisfaction guaranteed? Can J Hosp Pharm. 2013; 66(6): 355-360.
Ruiz-Millo O, Climente-Martí M, Navarro-Sanz JR. Patient and health professional satisfaction with an interdisciplinary patient safety program. Int J Clin Pharm. 2018; 40(3):635-641. doi: 10.1007/s11096-018-0627-7. Epub 2018 Mar 28. PMID: 29594676.
Ismail A, Gan YN, Ahmad N. Factors associated with patient satisfaction towards pharmacy services among out-patients attending public health clinics: Questionnaire development and its application. PLoS One. 2020;15(11):e0241082. doi: 10.1371/journal.pone.0241082. PMID: 33170854; PMCID: PMC7654767.
GEMA5.0. Guía española para el manejo del asma [Internet]. Madrid. Comité Ejecutivo de la GEMA; 2019. [Consultado 1 Feb 21]. Disponible en: https://www.semg.es/images/documentos/GEMA_5.0.pdf.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1):67-74. doi: 10.1097/00005650-198601000-00007. PMID: 3945130.
Amador N, Plaza F, Baixauli V, Palo J, Moranta F, Mendoza A. Programa de capacitación ‘epoca’: pacientes incluidos en la fase clínica. Farmacéuticos Comunitarios. 2020; 12 (Supl 2. Congreso SEFAC 2020): 474
Hernández Borge, J., L.M. Sierra Murillo, M.J. Antona Rodríguez, M.T. Gómez Vizcaíno, P. Cordero Montero. Nivel de adherencia y patrón de adherencia al tratamiento inhalado en pacientes con epoc y asma. Factores implicados. Rev Esp Patol Torac. 2021; 33 (1) 24 - 34
Cecere LM, Slatore CG, Uman JE et al. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD. 2012; 9: 251–258.
Villanueva Montes MA, Gullón Blanco JA, Rodriguez García C et al. Adhesión terapéutica a fármacos inhalados: Factores condicionantes. Arch Bronconeumol. 2016; (Espec Congre 1): 1-387.
Abdulsalim S, Unnikrishnan MK, Manu MK, Alrasheedy AA, Godman B, Morisky DE. Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: A randomized controlled study. Res Social Adm Pharm. 2018;14(10):909-914. doi: 10.1016/j.sapharm.2017.10.008. Epub 2017 Oct 26. PMID: 29104008.
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9. PMID: 22878278.
Rigueira AI. Cumplimiento terapéutico: ¿qué conocemos de España? Aten Primaria. 2001; 27(8):559-68
Mann D, Woodard M, Muntner P, Falzon L and Kronish I. Predictors of non-adherence to sta- tins: A systematic review and meta-analysis. Ann Pharmacother. 2010; 44:1410-21. http:// dx.doi.org/ 10.1345/aph.1P150
Sociología y Comunicación Encuesta sobre adherencia terapéutica en España. 2016. Madrid. Fundación Farmaindustria; 2016.
Taylor YJ, Tapp H, Shade LE, Liu TL, Mowrer JL, Dulin MF. Impact of shared decision making on asthma quality of life and asthma control among children. J Asthma. 2018; 55: 675-83.
Jordan JN, Wadsworth TG, Robinson R, Hruza H, Paul A, O'Connor SK. Patient Satisfaction with Pharmacist-Provided Health-Related Services in a Primary Care Clinic. Pharmacy (Basel). 2021; 9(4):187. doi: 10.3390/pharmacy9040187. PMID: 34842798; PMCID: PMC8628912.
Lee S, Godwin OP, Kim K, Lee E. Predictive factors of patient satisfaction with pharmacy services in South Korea: A cross-sectional study of national level data. PloS One. 2015;10(11): e0142269 10.1371/journal.pone.0142269
Soeiro OM, Tavares NU, Nascimento Júnior JM, Guerra Junior AA, Costa EA, Acurcio FD, et al. Patient satisfaction with pharmaceutical services in Brazilian primary health care. Rev Saude Publica. 2017;51(suppl 2):21s 10.11606/S1518-8787.2017051007145
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 María José Carpes Hernandez, Begoña Cerdá, Purificación Ballester Navarro, Pilar Zafrilla Rentero
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).
